AIM ImmunoTech, Inc. (AIM)
1.13
-0.13
(-10.32%)
USD |
NYAM |
Dec 31, 16:00
1.12
-0.01
(-0.88%)
After-Hours: 20:00
AIM ImmunoTech Research and Development Expense (TTM): 3.826M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Halozyme Therapeutics, Inc. | 70.03M |
| Perspective Therapeutics, Inc. | 61.22M |
| Protalix Biotherapeutics, Inc. | 18.06M |
| Electromed, Inc. | 1.071M |
| Armata Pharmaceuticals, Inc. | 26.10M |